Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Liver Cancer After Liver Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 0 results

Large-scale testing (Phase 3)UnknownNCT04237740
What this trial is testing

Relenvatinib in the Tatment of Recurrence of Hepatocellular Carcinoma After Liver Transplantation

Who this might be right for
Hepatocellular CarcinomaLiver Transplantation
RenJi Hospital 40
Testing effectiveness (Phase 2)Study completedNCT01624285
What this trial is testing

Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaLocalized Resectable Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
Jonsson Comprehensive Cancer Center 20
Early research (Phase 1)UnknownNCT04564313
What this trial is testing

Safety and Efficacy of Camrelizumab (Anti-PD-1 Antibody) in Recurrent HCC After Liver Transplantation

Who this might be right for
Hepatocellular CarcinomaLiver Transplantation
Third Affiliated Hospital, Sun Yat-Sen University 20
Testing effectiveness (Phase 2)WithdrawnNCT03634683
What this trial is testing

LioCyx in Patient With Recurrent HBV-related HCC Post Liver Transplantation

Who this might be right for
Recurrent Hepatocellular Carcinoma
Lion TCR Pte. Ltd.
Not applicableUnknownNCT05572528
What this trial is testing

Lenvatinib Therapy in HCC Patients After LDLT

Who this might be right for
Liver TransplantationHepatocellular Carcinoma
Kaoshiung Chang Gung Memorial Hospital 30
Not applicableStudy completedNCT06307158
What this trial is testing

Influence of Intraoperative Blood Salvage and Autotransfusion on Tumor Recurrence After Deceased Donor Liver Transplantation

Who this might be right for
Liver Transplant; Complications
Zhejiang University 998
Testing effectiveness (Phase 2)Looking for participantsNCT04204850
What this trial is testing

Cabozantinib to Treat Recurrent Liver Cancer Post Transplant

Who this might be right for
Hepatocellular CarcinomaRecurrent CancerLiver Transplant
University Health Network, Toronto 20
Not applicableStudy completedNCT04415567
What this trial is testing

Adjuvant Lenvatinib Prevents Recurrence of High-risk Patients With HBV-related HCC After Liver Transplantation

Who this might be right for
Hepatocellular Carcinoma
Jinyang Gu 23
Not applicableStudy completedNCT01198704
What this trial is testing

Study of Factors Predicting Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular CarcinomaLiver CirrhosisEvidence of Liver Transplantation
Assistance Publique - Hôpitaux de Paris 372
Early research (Phase 1)UnknownNCT02719782
What this trial is testing

TCR-Redirected T Cell Infusion in Subject With Recurrent HBV-related HCC Post Liver Transplantation

Who this might be right for
Recurrent Hepatocellular Carcinoma
Lion TCR Pte. Ltd. 10
Testing effectiveness (Phase 2)UnknownNCT05833126
What this trial is testing

Hepatic Arterial Infusion Chemotherapy in Combination With Atezolizumab and Bevacizumab for Second-line Treatment of Patients With Recurrent Liver Cancer After Liver Transplantation

Who this might be right for
Recurrent Liver Cancer After Liver Transplantation
Shuhong Yi 25
Not applicableStudy completedNCT00059267
What this trial is testing

Prevention of Recurrent Hepatitis B After Liver Transplantation

Who this might be right for
Hepatitis BCirrhosisAcute Liver Failure+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 317
Not applicableUnknownNCT01125020
What this trial is testing

Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver Transplantation

Who this might be right for
Liver TransplantationHepatocellular CarcinomaTumor Recurrence and Metastasis+2 more
Shanghai Jiao Tong University School of Medicine 150
Not applicableStudy completedNCT05200195
What this trial is testing

Deep Learning Model for the Prediction of Post-LT HCC Recurrence

Who this might be right for
Liver Transplant DisorderLiver CancerRecurrent Cancer
European Hepatocellular Cancer Liver Transplant Group 4,026